Third Rock Ventures, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 52 filers reported holding SAGE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Third Rock Ventures, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$272,664,000
-57.4%
6,442,916
-26.6%
25.46%
-61.8%
Q2 2015$640,434,000
+30.5%
8,773,073
-10.2%
66.66%
+27.3%
Q1 2015$490,901,000
+14.8%
9,773,073
-16.3%
52.36%
+49.7%
Q4 2014$427,525,000
+16.2%
11,681,0080.0%34.96%
-18.5%
Q3 2014$367,952,00011,681,00842.92%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Finepoint Capital LP 357,765$16,822,1105.82%
Palo Alto Investors LP 859,517$40,414,4893.26%
Boxer Capital, LLC 1,094,000$51,4402.39%
DAFNA Capital Management LLC 180,306$8,477,9882.32%
Bellevue Group AG 3,114,375$146,437,9132.09%
Saturn V Capital Management LP 70,559$3,317,6841.84%
SPHERA FUNDS MANAGEMENT LTD. 128,000$6,018,5600.94%
Artal Group S.A. 500,000$23,5100.73%
Parkman Healthcare Partners LLC 70,033$3,292,9520.57%
Integral Health Asset Management, LLC 80,000$3,761,6000.47%
View complete list of SAGE THERAPEUTICS INC shareholders